| |
| |
|
| Insider
Information: |
Mahatme Sandesh |
| Relationship: |
Director |
| City: |
Summit |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
24,760 |
|
|
Indirect Shares
|
12,012 |
|
|
| Direct
Value |
$2,693,074 |
|
|
|
Indirect Value
|
$1,572,371 |
|
|
| Total
Shares |
36,772 |
|
|
| Total
Value |
$4,265,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
EVP, CFO & CBO |
2020-07-08 |
20,260 |
2020-07-08 |
12,012 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2020-06-10 |
4,500 |
2020-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2020-07-08 |
4 |
OE |
$13.71 |
$74,941 |
D/D |
3,806 |
20,260 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2020-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,425 |
16,454 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
36,879 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-12-13 |
4 |
OE |
$13.71 |
$3,610,443 |
D/D |
125,000 |
155,179 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-12-13 |
4 |
AS |
$125.50 |
$15,687,500 |
D/D |
(125,000) |
30,179 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-08-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
42,535 |
30,179 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-08-21 |
4 |
D |
$101.50 |
$5,832,698 |
D/D |
(57,465) |
72,714 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-08-21 |
4 |
OE |
$23.85 |
$2,385,000 |
D/D |
100,000 |
130,179 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-08-15 |
4 |
OE |
$13.71 |
$241,232 |
D/D |
9,754 |
30,179 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,649 |
23,378 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-03-28 |
4 |
D |
$118.68 |
$350,462 |
D/D |
(2,953) |
20,425 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-03-19 |
4 |
D |
$126.47 |
$331,984 |
D/D |
(2,625) |
16,729 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-03-19 |
4 |
OE |
$13.71 |
$332,308 |
D/D |
15,486 |
19,354 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-02-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,781) |
3,868 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-02-07 |
4 |
OE |
$23.85 |
$1,550,250 |
D/D |
65,000 |
73,649 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-02-07 |
4 |
AS |
$145.00 |
$9,425,000 |
D/D |
(65,000) |
8,649 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-01-31 |
4 |
AS |
$130.72 |
$2,771,003 |
D/D |
(21,198) |
8,649 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-01-31 |
4 |
OE |
$23.85 |
$505,572 |
D/D |
21,198 |
29,847 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-01-30 |
4 |
AS |
$130.00 |
$5,694,260 |
D/D |
(43,802) |
8,649 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2019-01-30 |
4 |
OE |
$13.71 |
$800,077 |
D/D |
43,802 |
52,451 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2018-10-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
12,012 |
12,012 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2018-10-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,012 |
8,649 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2018-10-24 |
4 |
AS |
$127.74 |
$13,735,116 |
D/D |
(107,524) |
20,661 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
EVP, CFO & CBO |
• – – |
2018-10-24 |
4 |
OE |
$13.71 |
$1,330,389 |
D/D |
89,400 |
128,185 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
